

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cobalamin metabolic process (GO:0009235) | 9.11053703 |
| 2 | sequestering of extracellular ligand from receptor (GO:0035581) | 8.95462844 |
| 3 | keratan sulfate catabolic process (GO:0042340) | 7.61535438 |
| 4 | transcytosis (GO:0045056) | 7.36905407 |
| 5 | response to parathyroid hormone (GO:0071107) | 7.08150031 |
| 6 | chondrocyte proliferation (GO:0035988) | 6.82581641 |
| 7 | cholesterol catabolic process (GO:0006707) | 6.74772876 |
| 8 | sterol catabolic process (GO:0016127) | 6.74772876 |
| 9 | peptidyl-proline hydroxylation (GO:0019511) | 6.73721356 |
| 10 | cysteine metabolic process (GO:0006534) | 6.70570504 |
| 11 | intestinal absorption (GO:0050892) | 6.53080300 |
| 12 | regulation of phospholipase A2 activity (GO:0032429) | 6.39209306 |
| 13 | negative regulation of digestive system process (GO:0060457) | 6.36948084 |
| 14 | branched-chain amino acid catabolic process (GO:0009083) | 6.31998178 |
| 15 | glycolipid catabolic process (GO:0019377) | 5.90691785 |
| 16 | valine metabolic process (GO:0006573) | 5.89946644 |
| 17 | branched-chain amino acid metabolic process (GO:0009081) | 5.89464857 |
| 18 | membrane lipid catabolic process (GO:0046466) | 5.70156804 |
| 19 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 5.58460304 |
| 20 | ceramide catabolic process (GO:0046514) | 5.36774755 |
| 21 | protein hydroxylation (GO:0018126) | 5.21928580 |
| 22 | extracellular regulation of signal transduction (GO:1900115) | 5.14476495 |
| 23 | extracellular negative regulation of signal transduction (GO:1900116) | 5.14476495 |
| 24 | cellular modified amino acid catabolic process (GO:0042219) | 5.12283761 |
| 25 | mitochondrial calcium ion transport (GO:0006851) | 4.95117415 |
| 26 | proline biosynthetic process (GO:0006561) | 4.93777992 |
| 27 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 4.93695481 |
| 28 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 4.93695481 |
| 29 | homocysteine metabolic process (GO:0050667) | 4.87729196 |
| 30 | collagen fibril organization (GO:0030199) | 4.87116012 |
| 31 | aspartate family amino acid catabolic process (GO:0009068) | 4.82710285 |
| 32 | COPI coating of Golgi vesicle (GO:0048205) | 4.75921224 |
| 33 | Golgi transport vesicle coating (GO:0048200) | 4.75921224 |
| 34 | enteric nervous system development (GO:0048484) | 4.64979306 |
| 35 | mesenchymal-epithelial cell signaling (GO:0060638) | 4.64172322 |
| 36 | cell migration involved in heart development (GO:0060973) | 4.60096884 |
| 37 | bone trabecula formation (GO:0060346) | 4.55363870 |
| 38 | diaphragm development (GO:0060539) | 4.48214680 |
| 39 | negative regulation of biomineral tissue development (GO:0070168) | 4.40785407 |
| 40 | leukotriene biosynthetic process (GO:0019370) | 4.39989615 |
| 41 | zinc ion transport (GO:0006829) | 4.34978818 |
| 42 | serine family amino acid biosynthetic process (GO:0009070) | 4.33464732 |
| 43 | negative regulation of bone mineralization (GO:0030502) | 4.31135618 |
| 44 | proline metabolic process (GO:0006560) | 4.27753049 |
| 45 | cell differentiation involved in metanephros development (GO:0072202) | 4.26106849 |
| 46 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.25539295 |
| 47 | lung vasculature development (GO:0060426) | 4.21754915 |
| 48 | ganglion development (GO:0061548) | 4.19652076 |
| 49 | positive regulation of heat generation (GO:0031652) | 4.17666407 |
| 50 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 4.17233091 |
| 51 | axon extension involved in axon guidance (GO:0048846) | 4.17233091 |
| 52 | dermatan sulfate biosynthetic process (GO:0030208) | 4.14171568 |
| 53 | intestinal epithelial cell development (GO:0060576) | 4.07317502 |
| 54 | mitochondrion distribution (GO:0048311) | 4.05216288 |
| 55 | negative regulation of BMP signaling pathway (GO:0030514) | 4.04766429 |
| 56 | regulation of fever generation (GO:0031620) | 4.03521708 |
| 57 | positive regulation of nuclease activity (GO:0032075) | 4.03136528 |
| 58 | lysine catabolic process (GO:0006554) | 4.02171519 |
| 59 | lysine metabolic process (GO:0006553) | 4.02171519 |
| 60 | cell aggregation (GO:0098743) | 4.01009305 |
| 61 | cartilage condensation (GO:0001502) | 4.01009305 |
| 62 | response to endoplasmic reticulum stress (GO:0034976) | 3.99117972 |
| 63 | skeletal muscle organ development (GO:0060538) | 3.95089119 |
| 64 | protein maturation by protein folding (GO:0022417) | 3.87395931 |
| 65 | type B pancreatic cell proliferation (GO:0044342) | 3.83751179 |
| 66 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 3.83159833 |
| 67 | dermatan sulfate metabolic process (GO:0030205) | 3.82164688 |
| 68 | chondrocyte development (GO:0002063) | 3.81716980 |
| 69 | respiratory tube development (GO:0030323) | 3.81617153 |
| 70 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.78705720 |
| 71 | coenzyme catabolic process (GO:0009109) | 3.78410222 |
| 72 | extracellular matrix assembly (GO:0085029) | 3.78310195 |
| 73 | cartilage morphogenesis (GO:0060536) | 3.75250923 |
| 74 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.72671394 |
| 75 | negative regulation of osteoblast proliferation (GO:0033689) | 3.72477708 |
| 76 | steroid catabolic process (GO:0006706) | 3.72431778 |
| 77 | ossification (GO:0001503) | 3.68618157 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 3.67318468 |
| 79 | cellular response to unfolded protein (GO:0034620) | 3.67285094 |
| 80 | regulation of nuclease activity (GO:0032069) | 3.63612460 |
| 81 | L-phenylalanine catabolic process (GO:0006559) | 3.61438459 |
| 82 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.61438459 |
| 83 | trivalent inorganic anion homeostasis (GO:0072506) | 3.61118787 |
| 84 | phosphate ion homeostasis (GO:0055062) | 3.61118787 |
| 85 | maintenance of protein localization in organelle (GO:0072595) | 3.60522760 |
| 86 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.60222190 |
| 87 | signal peptide processing (GO:0006465) | 3.58123463 |
| 88 | embryonic viscerocranium morphogenesis (GO:0048703) | 3.57130878 |
| 89 | neutrophil mediated immunity (GO:0002446) | 3.57065552 |
| 90 | blood vessel maturation (GO:0001955) | 3.56973460 |
| 91 | regulation of bone mineralization (GO:0030500) | 3.56317047 |
| 92 | ER overload response (GO:0006983) | 3.55265062 |
| 93 | biomineral tissue development (GO:0031214) | 3.54253728 |
| 94 | negative regulation of ossification (GO:0030279) | 3.51104942 |
| 95 | 4-hydroxyproline metabolic process (GO:0019471) | 3.50360571 |
| 96 | peptide catabolic process (GO:0043171) | 3.50204270 |
| 97 | myoblast migration (GO:0051451) | 3.49935316 |
| 98 | extracellular fibril organization (GO:0043206) | 3.49688918 |
| 99 | ER-nucleus signaling pathway (GO:0006984) | 3.49512412 |
| 100 | embryonic cranial skeleton morphogenesis (GO:0048701) | 3.48352997 |
| 101 | L-phenylalanine metabolic process (GO:0006558) | 3.47442436 |
| 102 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.47442436 |
| 103 | cellular response to topologically incorrect protein (GO:0035967) | 3.47427231 |
| 104 | regulation of biomineral tissue development (GO:0070167) | 3.46986819 |
| 105 | muscle cell migration (GO:0014812) | 3.46260873 |
| 106 | smooth muscle tissue development (GO:0048745) | 3.44639402 |
| 107 | behavioral response to nicotine (GO:0035095) | 3.44073210 |
| 108 | sphingolipid catabolic process (GO:0030149) | 3.35493155 |
| 109 | biotin metabolic process (GO:0006768) | 3.34223317 |
| 110 | endocrine pancreas development (GO:0031018) | 3.34222118 |
| 111 | polarized epithelial cell differentiation (GO:0030859) | 3.33978595 |
| 112 | metanephric mesenchyme development (GO:0072075) | 3.33897694 |
| 113 | cellular protein catabolic process (GO:0044257) | 3.33237642 |
| 114 | protein heterotrimerization (GO:0070208) | 3.32771046 |
| 115 | positive regulation of extracellular matrix organization (GO:1903055) | 3.31877631 |
| 116 | substrate adhesion-dependent cell spreading (GO:0034446) | 3.30590634 |
| 117 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.30320959 |
| 118 | endochondral ossification (GO:0001958) | 3.25592903 |
| 119 | replacement ossification (GO:0036075) | 3.25592903 |
| 120 | mesenchymal cell differentiation (GO:0048762) | 3.25130844 |
| 121 | sympathetic nervous system development (GO:0048485) | 3.21268391 |
| 122 | collagen metabolic process (GO:0032963) | 3.21253831 |
| 123 | glutamine metabolic process (GO:0006541) | 3.20861336 |
| 124 | creatine metabolic process (GO:0006600) | 3.19906278 |
| 125 | substrate-dependent cell migration (GO:0006929) | 3.16665997 |
| 126 | multicellular organismal metabolic process (GO:0044236) | 3.16521866 |
| 127 | kidney mesenchyme development (GO:0072074) | 3.13790955 |
| 128 | regulation of extracellular matrix disassembly (GO:0010715) | 3.13399020 |
| 129 | regulation of heat generation (GO:0031650) | 3.13321753 |
| 130 | tongue development (GO:0043586) | 3.11735403 |
| 131 | dopaminergic neuron differentiation (GO:0071542) | 3.11516443 |
| 132 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.10692177 |
| 133 | COPII vesicle coating (GO:0048208) | 3.10058636 |
| 134 | paraxial mesoderm development (GO:0048339) | 3.08562152 |
| 135 | short-chain fatty acid metabolic process (GO:0046459) | 3.07104506 |
| 136 | positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) | 3.07000302 |
| 137 | positive regulation of cell cycle G2/M phase transition (GO:1902751) | 3.07000302 |
| 138 | icosanoid secretion (GO:0032309) | 3.06443121 |
| 139 | arachidonic acid secretion (GO:0050482) | 3.06443121 |
| 140 | multicellular organismal catabolic process (GO:0044243) | 3.05582618 |
| 141 | lymphangiogenesis (GO:0001946) | 3.05266928 |
| 142 | regulation of digestive system process (GO:0044058) | 3.04913731 |
| 143 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.04786455 |
| 144 | extracellular matrix organization (GO:0030198) | 3.04776848 |
| 145 | positive regulation of fibroblast migration (GO:0010763) | 3.03876998 |
| 146 | tetrapyrrole metabolic process (GO:0033013) | 3.03806892 |
| 147 | extracellular structure organization (GO:0043062) | 3.03761915 |
| 148 | antibacterial humoral response (GO:0019731) | 3.03283999 |
| 149 | negative chemotaxis (GO:0050919) | 3.02683459 |
| 150 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 3.02030122 |
| 151 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.01797311 |
| 152 | pancreas development (GO:0031016) | 3.01404404 |
| 153 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.00376124 |
| 154 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.99811916 |
| 155 | collagen catabolic process (GO:0030574) | 2.99203480 |
| 156 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.98122990 |
| 157 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.96865569 |
| 158 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.94457221 |
| 159 | glomerulus development (GO:0032835) | 2.94039027 |
| 160 | keratan sulfate biosynthetic process (GO:0018146) | 2.93025147 |
| 161 | fibril organization (GO:0097435) | 2.92396130 |
| 162 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.91248126 |
| 163 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.89978208 |
| 164 | chondroitin sulfate catabolic process (GO:0030207) | 2.89966722 |
| 165 | peptidyl-asparagine modification (GO:0018196) | 2.89771176 |
| 166 | response to unfolded protein (GO:0006986) | 2.89278909 |
| 167 | cellular amino acid catabolic process (GO:0009063) | 2.88059607 |
| 168 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.87895142 |
| 169 | embryonic body morphogenesis (GO:0010172) | 2.87779798 |
| 170 | mesenchyme morphogenesis (GO:0072132) | 2.86898690 |
| 171 | extracellular matrix disassembly (GO:0022617) | 2.86727980 |
| 172 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.86719110 |
| 173 | glycine transport (GO:0015816) | 2.86230921 |
| 174 | cell proliferation involved in metanephros development (GO:0072203) | 2.85601835 |
| 175 | cell redox homeostasis (GO:0045454) | 2.85459580 |
| 176 | positive regulation of digestive system process (GO:0060456) | 2.84334310 |
| 177 | L-serine metabolic process (GO:0006563) | 2.84151908 |
| 178 | pericardium development (GO:0060039) | 2.83918798 |
| 179 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.82813432 |
| 180 | establishment of apical/basal cell polarity (GO:0035089) | 2.82805347 |
| 181 | midgut development (GO:0007494) | 2.81256402 |
| 182 | positive regulation of mesenchymal cell proliferation (GO:0002053) | 2.80729869 |
| 183 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.80527761 |
| 184 | sulfur amino acid biosynthetic process (GO:0000097) | 2.80398605 |
| 185 | lung secretory cell differentiation (GO:0061140) | 2.79415073 |
| 186 | positive regulation of receptor internalization (GO:0002092) | 2.77294321 |
| 187 | negative regulation of cell fate commitment (GO:0010454) | 2.77210494 |
| 188 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.76941229 |
| 189 | regulation of BMP signaling pathway (GO:0030510) | 2.76865527 |
| 190 | response to topologically incorrect protein (GO:0035966) | 2.76673200 |
| 191 | bone development (GO:0060348) | 2.76333249 |
| 192 | GDP-mannose metabolic process (GO:0019673) | 2.75503630 |
| 193 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175) | 2.75427083 |
| 194 | antimicrobial humoral response (GO:0019730) | 2.71909510 |
| 195 | intestinal cholesterol absorption (GO:0030299) | 15.2840298 |
| 196 | exocrine pancreas development (GO:0031017) | 15.2105293 |
| 197 | * digestion (GO:0007586) | 12.5444043 |
| 198 | protein retention in ER lumen (GO:0006621) | 11.1809614 |
| 199 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 10.4149206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 7.17691280 |
| 2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.88771619 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.63124865 |
| 4 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.52173359 |
| 5 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.43934615 |
| 6 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 3.36139742 |
| 7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.16011227 |
| 8 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.03673741 |
| 9 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.96518772 |
| 10 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.84860314 |
| 11 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.77157036 |
| 12 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 2.72672170 |
| 13 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.60091612 |
| 14 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.51405896 |
| 15 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.45719865 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.37756742 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.37142774 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.34289105 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.32820155 |
| 20 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.30931808 |
| 21 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.22851940 |
| 22 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.19641621 |
| 23 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.18229560 |
| 24 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.15434860 |
| 25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.14950218 |
| 26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.12828994 |
| 27 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.11546385 |
| 28 | * CJUN_26792858_Chip-Seq_BT549_Human | 2.10975088 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.09883517 |
| 30 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.08476022 |
| 31 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.06526460 |
| 32 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.04195536 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.03358215 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.03128653 |
| 35 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.99289472 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.98272378 |
| 37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.98225974 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.95271656 |
| 39 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.89647078 |
| 40 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.84383956 |
| 41 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.83997672 |
| 42 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.82505400 |
| 43 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.81336796 |
| 44 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.80943337 |
| 45 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.79851272 |
| 46 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.77259774 |
| 47 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.76263923 |
| 48 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.75606418 |
| 49 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.74002969 |
| 50 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.69987289 |
| 51 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.67307933 |
| 52 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.66852967 |
| 53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.66257964 |
| 54 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.66040963 |
| 55 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.66040963 |
| 56 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.66040963 |
| 57 | GATA1_22025678_ChIP-Seq_K562_Human | 1.62205308 |
| 58 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.60082823 |
| 59 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.59786613 |
| 60 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.59284035 |
| 61 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.59284035 |
| 62 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.59129067 |
| 63 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.55912487 |
| 64 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.55056106 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.52965415 |
| 66 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.51530003 |
| 67 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.50161888 |
| 68 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.49848001 |
| 69 | TP53_16413492_ChIP-PET_HCT116_Human | 1.48584175 |
| 70 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.47738446 |
| 71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.47341069 |
| 72 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.46674674 |
| 73 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44604187 |
| 74 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.43341833 |
| 75 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.43083495 |
| 76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.40085133 |
| 77 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.39798894 |
| 78 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 1.39032591 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.37775250 |
| 80 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.37193625 |
| 81 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.36016591 |
| 82 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.34856021 |
| 83 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34536347 |
| 84 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.30011367 |
| 85 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.23645994 |
| 86 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.21979692 |
| 87 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.21429450 |
| 88 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20847228 |
| 89 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19432489 |
| 90 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.18931112 |
| 91 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.18231782 |
| 92 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.18084086 |
| 93 | P300_19829295_ChIP-Seq_ESCs_Human | 1.17888427 |
| 94 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.17360535 |
| 95 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.16930660 |
| 96 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.16082065 |
| 97 | FUS_26573619_Chip-Seq_HEK293_Human | 1.16006341 |
| 98 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.15889476 |
| 99 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.15729282 |
| 100 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.15460411 |
| 101 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.14861922 |
| 102 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14426319 |
| 103 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.13864289 |
| 104 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.12287758 |
| 105 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10884128 |
| 106 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.09090150 |
| 107 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08915494 |
| 108 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.08871086 |
| 109 | P68_20966046_ChIP-Seq_HELA_Human | 1.08428947 |
| 110 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.07176992 |
| 111 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.06755150 |
| 112 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.06325449 |
| 113 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.05819642 |
| 114 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05646566 |
| 115 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.05517590 |
| 116 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04966183 |
| 117 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04945060 |
| 118 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04628296 |
| 119 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03986256 |
| 120 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03301051 |
| 121 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03281780 |
| 122 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03111690 |
| 123 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.02743878 |
| 124 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02631324 |
| 125 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02463403 |
| 126 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.02197936 |
| 127 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.01489344 |
| 128 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01479423 |
| 129 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01291803 |
| 130 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01157402 |
| 131 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.00912928 |
| 132 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.99791341 |
| 133 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.99302524 |
| 134 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.99270653 |
| 135 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.98954507 |
| 136 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98628117 |
| 137 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98499276 |
| 138 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98442329 |
| 139 | EWS_26573619_Chip-Seq_HEK293_Human | 0.98197704 |
| 140 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98063627 |
| 141 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.97705351 |
| 142 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97454583 |
| 143 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97177794 |
| 144 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.96457066 |
| 145 | ERA_21632823_ChIP-Seq_H3396_Human | 0.95746904 |
| 146 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95521006 |
| 147 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95517800 |
| 148 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.95466880 |
| 149 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.95403509 |
| 150 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.95270387 |
| 151 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94909157 |
| 152 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.94802903 |
| 153 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.94268775 |
| 154 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.93770720 |
| 155 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.93617502 |
| 156 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.92568230 |
| 157 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.92474921 |
| 158 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.92474921 |
| 159 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.92191280 |
| 160 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91820268 |
| 161 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.90451730 |
| 162 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.86001883 |
| 163 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85353327 |
| 164 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.85123232 |
| 165 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.84043961 |
| 166 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.83725389 |
| 167 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.83457761 |
| 168 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.83363372 |
| 169 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.83093261 |
| 170 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.81312121 |
| 171 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81285397 |
| 172 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.79798601 |
| 173 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.79374069 |
| 174 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.78927911 |
| 175 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78805451 |
| 176 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.78626828 |
| 177 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.78413727 |
| 178 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.78151033 |
| 179 | AR_20517297_ChIP-Seq_VCAP_Human | 0.77698295 |
| 180 | SA1_27219007_Chip-Seq_Bcells_Human | 0.77421190 |
| 181 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.77128931 |
| 182 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.76513048 |
| 183 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.75227171 |
| 184 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.74830879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0001666_abnormal_nutrient_absorption | 9.24926836 |
| 2 | MP0005220_abnormal_exocrine_pancreas | 7.55892448 |
| 3 | MP0003868_abnormal_feces_composition | 6.29452571 |
| 4 | MP0005503_abnormal_tendon_morphology | 6.22829606 |
| 5 | MP0005275_abnormal_skin_tensile | 5.44219744 |
| 6 | * MP0005365_abnormal_bile_salt | 4.73085784 |
| 7 | * MP0005083_abnormal_biliary_tract | 4.35172985 |
| 8 | MP0001542_abnormal_bone_strength | 3.52291185 |
| 9 | MP0003959_abnormal_lean_body | 3.35223989 |
| 10 | MP0008004_abnormal_stomach_pH | 3.29845695 |
| 11 | MP0009250_abnormal_appendicular_skeleto | 3.13030407 |
| 12 | * MP0001664_abnormal_digestion | 2.74802180 |
| 13 | MP0003279_aneurysm | 2.69634665 |
| 14 | MP0001986_abnormal_taste_sensitivity | 2.66386494 |
| 15 | MP0002638_abnormal_pupillary_reflex | 2.62795190 |
| 16 | MP0005257_abnormal_intraocular_pressure | 2.55012211 |
| 17 | MP0002139_abnormal_hepatobiliary_system | 2.49240733 |
| 18 | MP0002277_abnormal_respiratory_mucosa | 2.39708973 |
| 19 | MP0005332_abnormal_amino_acid | 2.32190994 |
| 20 | * MP0002693_abnormal_pancreas_physiology | 2.31070193 |
| 21 | MP0002108_abnormal_muscle_morphology | 2.27157312 |
| 22 | MP0005508_abnormal_skeleton_morphology | 2.22487733 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 2.15706442 |
| 24 | MP0004264_abnormal_extraembryonic_tissu | 2.13700868 |
| 25 | MP0002998_abnormal_bone_remodeling | 2.12728504 |
| 26 | MP0002115_abnormal_skeleton_extremities | 2.02120069 |
| 27 | * MP0005084_abnormal_gallbladder_morpholo | 1.90771827 |
| 28 | MP0003638_abnormal_response/metabolism_ | 1.84389354 |
| 29 | * MP0005085_abnormal_gallbladder_physiolo | 1.75045768 |
| 30 | MP0010368_abnormal_lymphatic_system | 1.74818086 |
| 31 | MP0005171_absent_coat_pigmentation | 1.73186294 |
| 32 | MP0000534_abnormal_ureter_morphology | 1.72503378 |
| 33 | MP0004233_abnormal_muscle_weight | 1.71139414 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.71078240 |
| 35 | MP0003122_maternal_imprinting | 1.70202125 |
| 36 | MP0005390_skeleton_phenotype | 1.69926626 |
| 37 | MP0000470_abnormal_stomach_morphology | 1.69036542 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.68684502 |
| 39 | MP0001299_abnormal_eye_distance/ | 1.68178731 |
| 40 | MP0000163_abnormal_cartilage_morphology | 1.66647773 |
| 41 | * MP0001944_abnormal_pancreas_morphology | 1.66589573 |
| 42 | MP0002109_abnormal_limb_morphology | 1.63516185 |
| 43 | MP0000428_abnormal_craniofacial_morphol | 1.59885391 |
| 44 | MP0000432_abnormal_head_morphology | 1.58399342 |
| 45 | MP0005360_urolithiasis | 1.52835280 |
| 46 | MP0008961_abnormal_basal_metabolism | 1.49537513 |
| 47 | MP0005451_abnormal_body_composition | 1.43525000 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 1.43452540 |
| 49 | MP0005408_hypopigmentation | 1.42222520 |
| 50 | MP0010234_abnormal_vibrissa_follicle | 1.39923680 |
| 51 | MP0002113_abnormal_skeleton_development | 1.38451082 |
| 52 | MP0000767_abnormal_smooth_muscle | 1.38358928 |
| 53 | MP0002295_abnormal_pulmonary_circulatio | 1.37950134 |
| 54 | MP0003935_abnormal_craniofacial_develop | 1.37347841 |
| 55 | MP0005187_abnormal_penis_morphology | 1.36653517 |
| 56 | * MP0002118_abnormal_lipid_homeostasis | 1.33365404 |
| 57 | MP0000569_abnormal_digit_pigmentation | 1.32056020 |
| 58 | MP0003115_abnormal_respiratory_system | 1.27529578 |
| 59 | MP0002060_abnormal_skin_morphology | 1.27432156 |
| 60 | MP0004782_abnormal_surfactant_physiolog | 1.25522804 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.25460731 |
| 62 | MP0002116_abnormal_craniofacial_bone | 1.25047090 |
| 63 | MP0004043_abnormal_pH_regulation | 1.24773245 |
| 64 | MP0005197_abnormal_uvea_morphology | 1.24518404 |
| 65 | MP0003566_abnormal_cell_adhesion | 1.23312976 |
| 66 | MP0003283_abnormal_digestive_organ | 1.22089119 |
| 67 | MP0003252_abnormal_bile_duct | 1.20018344 |
| 68 | MP0005165_increased_susceptibility_to | 1.19966528 |
| 69 | MP0001873_stomach_inflammation | 1.18609873 |
| 70 | MP0005058_abnormal_lysosome_morphology | 1.17649824 |
| 71 | MP0002928_abnormal_bile_duct | 1.16889449 |
| 72 | MP0003941_abnormal_skin_development | 1.16369660 |
| 73 | MP0005623_abnormal_meninges_morphology | 1.14860009 |
| 74 | MP0003937_abnormal_limbs/digits/tail_de | 1.12444166 |
| 75 | MP0002751_abnormal_autonomic_nervous | 1.12256927 |
| 76 | MP0005023_abnormal_wound_healing | 1.12158016 |
| 77 | MP0000049_abnormal_middle_ear | 1.10363645 |
| 78 | * MP0005448_abnormal_energy_balance | 1.09139069 |
| 79 | MP0006054_spinal_hemorrhage | 1.07362252 |
| 80 | MP0000490_abnormal_crypts_of | 1.05655638 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 1.03919139 |
| 82 | MP0002233_abnormal_nose_morphology | 1.03826353 |
| 83 | MP0001879_abnormal_lymphatic_vessel | 1.01880151 |
| 84 | MP0002168_other_aberrant_phenotype | 0.99203465 |
| 85 | MP0009384_cardiac_valve_regurgitation | 0.98624094 |
| 86 | MP0008438_abnormal_cutaneous_collagen | 0.96693777 |
| 87 | MP0002933_joint_inflammation | 0.96685157 |
| 88 | MP0001765_abnormal_ion_homeostasis | 0.94983443 |
| 89 | MP0000751_myopathy | 0.94833428 |
| 90 | MP0002876_abnormal_thyroid_physiology | 0.94508397 |
| 91 | MP0000566_synostosis | 0.93929511 |
| 92 | MP0004134_abnormal_chest_morphology | 0.93889794 |
| 93 | MP0002114_abnormal_axial_skeleton | 0.93756570 |
| 94 | MP0001663_abnormal_digestive_system | 0.91844835 |
| 95 | MP0005636_abnormal_mineral_homeostasis | 0.91225462 |
| 96 | MP0003953_abnormal_hormone_level | 0.90700474 |
| 97 | MP0003091_abnormal_cell_migration | 0.90553393 |
| 98 | MP0002932_abnormal_joint_morphology | 0.90176078 |
| 99 | MP0000613_abnormal_salivary_gland | 0.89688600 |
| 100 | MP0003755_abnormal_palate_morphology | 0.89633251 |
| 101 | MP0000759_abnormal_skeletal_muscle | 0.89162616 |
| 102 | MP0002938_white_spotting | 0.88206422 |
| 103 | MP0003186_abnormal_redox_activity | 0.87594900 |
| 104 | MP0000733_abnormal_muscle_development | 0.87426968 |
| 105 | MP0001958_emphysema | 0.85098563 |
| 106 | MP0008789_abnormal_olfactory_epithelium | 0.83982990 |
| 107 | MP0001756_abnormal_urination | 0.83176396 |
| 108 | MP0005377_hearing/vestibular/ear_phenot | 0.83001843 |
| 109 | MP0003878_abnormal_ear_physiology | 0.83001843 |
| 110 | MP0001177_atelectasis | 0.80325009 |
| 111 | MP0001243_abnormal_dermal_layer | 0.79750545 |
| 112 | MP0005381_digestive/alimentary_phenotyp | 0.75586194 |
| 113 | MP0000427_abnormal_hair_cycle | 0.74857541 |
| 114 | MP0002098_abnormal_vibrissa_morphology | 0.74546297 |
| 115 | MP0000762_abnormal_tongue_morphology | 0.73585025 |
| 116 | MP0003385_abnormal_body_wall | 0.72910506 |
| 117 | MP0004019_abnormal_vitamin_homeostasis | 0.71479208 |
| 118 | MP0005369_muscle_phenotype | 0.71163312 |
| 119 | MP0003123_paternal_imprinting | 0.71007106 |
| 120 | MP0002128_abnormal_blood_circulation | 0.70642395 |
| 121 | MP0005452_abnormal_adipose_tissue | 0.70015842 |
| 122 | MP0005076_abnormal_cell_differentiation | 0.66682498 |
| 123 | MP0001731_abnormal_postnatal_growth | 0.66456471 |
| 124 | MP0002133_abnormal_respiratory_system | 0.66017934 |
| 125 | MP0005388_respiratory_system_phenotype | 0.66017934 |
| 126 | MP0000003_abnormal_adipose_tissue | 0.65785214 |
| 127 | MP0010329_abnormal_lipoprotein_level | 0.65304047 |
| 128 | MP0005395_other_phenotype | 0.64250909 |
| 129 | MP0003567_abnormal_fetal_cardiomyocyte | 0.63210564 |
| 130 | MP0003936_abnormal_reproductive_system | 0.63147870 |
| 131 | MP0002089_abnormal_postnatal_growth/wei | 0.62787922 |
| 132 | MP0006036_abnormal_mitochondrial_physio | 0.62576056 |
| 133 | MP0004858_abnormal_nervous_system | 0.62034261 |
| 134 | MP0002796_impaired_skin_barrier | 0.61866049 |
| 135 | MP0002136_abnormal_kidney_physiology | 0.60933941 |
| 136 | MP0005193_abnormal_anterior_eye | 0.59121814 |
| 137 | MP0005319_abnormal_enzyme/_coenzyme | 0.58428775 |
| 138 | MP0005499_abnormal_olfactory_system | 0.58097746 |
| 139 | MP0005394_taste/olfaction_phenotype | 0.58097746 |
| 140 | MP0001175_abnormal_lung_morphology | 0.57645949 |
| 141 | MP0002697_abnormal_eye_size | 0.57472382 |
| 142 | MP0001764_abnormal_homeostasis | 0.57220388 |
| 143 | MP0004272_abnormal_basement_membrane | 0.55790202 |
| 144 | MP0003795_abnormal_bone_structure | 0.55076144 |
| 145 | MP0009765_abnormal_xenobiotic_induced | 0.54533516 |
| 146 | MP0002111_abnormal_tail_morphology | 0.53203625 |
| 147 | MP0000598_abnormal_liver_morphology | 0.53034693 |
| 148 | MP0003448_altered_tumor_morphology | 0.52445027 |
| 149 | MP0000462_abnormal_digestive_system | 0.52408359 |
| 150 | MP0000371_diluted_coat_color | 0.52310994 |
| 151 | MP0005595_abnormal_vascular_smooth | 0.51776799 |
| 152 | MP0002896_abnormal_bone_mineralization | 0.49373748 |
| 153 | MP0003942_abnormal_urinary_system | 0.49164643 |
| 154 | MP0002249_abnormal_larynx_morphology | 0.47915456 |
| 155 | MP0010030_abnormal_orbit_morphology | 0.47531610 |
| 156 | MP0005647_abnormal_sex_gland | 0.46496457 |
| 157 | MP0005334_abnormal_fat_pad | 0.46045170 |
| 158 | MP0009642_abnormal_blood_homeostasis | 0.45871526 |
| 159 | MP0000749_muscle_degeneration | 0.45102044 |
| 160 | MP0001270_distended_abdomen | 0.45053496 |
| 161 | MP0001845_abnormal_inflammatory_respons | 0.44628260 |
| 162 | MP0001614_abnormal_blood_vessel | 0.44576782 |
| 163 | MP0009780_abnormal_chondrocyte_physiolo | 0.44572119 |
| 164 | MP0010386_abnormal_urinary_bladder | 0.42777769 |
| 165 | MP0009703_decreased_birth_body | 0.42628066 |
| 166 | MP0008875_abnormal_xenobiotic_pharmacok | 0.41894918 |
| 167 | MP0000367_abnormal_coat/_hair | 0.40853318 |
| 168 | MP0000377_abnormal_hair_follicle | 0.38479784 |
| 169 | MP0000538_abnormal_urinary_bladder | 0.38346129 |
| 170 | MP0000778_abnormal_nervous_system | 0.37076250 |
| 171 | MP0000537_abnormal_urethra_morphology | 0.34690944 |
| 172 | MP0003183_abnormal_peptide_metabolism | 0.34686232 |
| 173 | * MP0002069_abnormal_eating/drinking_beha | 0.34665059 |
| 174 | * MP0005535_abnormal_body_temperature | 0.34282733 |
| 175 | * MP0002135_abnormal_kidney_morphology | 0.34179376 |
| 176 | MP0003045_fibrosis | 0.33642795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Papilledema (HP:0001085) | 8.01400452 |
| 2 | Gout (HP:0001997) | 7.76964285 |
| 3 | Steatorrhea (HP:0002570) | 7.24371065 |
| 4 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 6.87026479 |
| 5 | Overgrowth (HP:0001548) | 5.99492327 |
| 6 | Fat malabsorption (HP:0002630) | 5.84533459 |
| 7 | Hypophosphatemic rickets (HP:0004912) | 5.54115950 |
| 8 | Broad ribs (HP:0000885) | 5.25105820 |
| 9 | Protrusio acetabuli (HP:0003179) | 5.11688746 |
| 10 | Asymmetry of the thorax (HP:0001555) | 4.81430318 |
| 11 | Short chin (HP:0000331) | 4.68681757 |
| 12 | Aortic aneurysm (HP:0004942) | 4.58865859 |
| 13 | Exocrine pancreatic insufficiency (HP:0001738) | 4.48328373 |
| 14 | Tubulointerstitial fibrosis (HP:0005576) | 4.44182748 |
| 15 | Increased density of long bones (HP:0006392) | 4.39876411 |
| 16 | Vascular tortuosity (HP:0004948) | 4.27060006 |
| 17 | Decreased subcutaneous fat (HP:0001002) | 4.26091334 |
| 18 | Increased purine levels (HP:0004368) | 4.15400934 |
| 19 | Hyperuricemia (HP:0002149) | 4.15400934 |
| 20 | Metaphyseal dysplasia (HP:0100255) | 4.10240205 |
| 21 | Type I diabetes mellitus (HP:0100651) | 4.04244467 |
| 22 | Renal salt wasting (HP:0000127) | 3.99873591 |
| 23 | Spinal cord compression (HP:0002176) | 3.96120419 |
| 24 | Tubulointerstitial nephritis (HP:0001970) | 3.94620151 |
| 25 | Mild short stature (HP:0003502) | 3.89544028 |
| 26 | Abnormality of the vertebral endplates (HP:0005106) | 3.89170179 |
| 27 | Spondylolisthesis (HP:0003302) | 3.87805807 |
| 28 | Aortic dissection (HP:0002647) | 3.87351278 |
| 29 | Abnormal pancreas size (HP:0012094) | 3.81507146 |
| 30 | Abnormality of subcutaneous fat tissue (HP:0001001) | 3.81002993 |
| 31 | Broad metatarsal (HP:0001783) | 3.75162684 |
| 32 | Ketoacidosis (HP:0001993) | 3.74703922 |
| 33 | Ketosis (HP:0001946) | 3.74512405 |
| 34 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.68133132 |
| 35 | Arterial tortuosity (HP:0005116) | 3.60717496 |
| 36 | Maternal diabetes (HP:0009800) | 3.59821228 |
| 37 | Facial diplegia (HP:0001349) | 3.58561429 |
| 38 | Pancreatitis (HP:0001733) | 3.57442408 |
| 39 | Premature rupture of membranes (HP:0001788) | 3.56635271 |
| 40 | Abnormality of renal excretion (HP:0011036) | 3.54583223 |
| 41 | Hyperactive renin-angiotensin system (HP:0000841) | 3.53011747 |
| 42 | Hyperglycinuria (HP:0003108) | 3.52601727 |
| 43 | Tubular atrophy (HP:0000092) | 3.46071555 |
| 44 | Coronal craniosynostosis (HP:0004440) | 3.39891691 |
| 45 | Absent eyelashes (HP:0000561) | 3.38540616 |
| 46 | Abnormality of the intrinsic pathway (HP:0010989) | 3.37242745 |
| 47 | Hyperglycinemia (HP:0002154) | 3.36825167 |
| 48 | Cervical subluxation (HP:0003308) | 3.35164820 |
| 49 | Hypoplasia of the pons (HP:0012110) | 3.34875160 |
| 50 | Hypoproteinemia (HP:0003075) | 3.30429550 |
| 51 | Shallow orbits (HP:0000586) | 3.27833943 |
| 52 | Craniofacial hyperostosis (HP:0004493) | 3.27554504 |
| 53 | Metaphyseal cupping (HP:0003021) | 3.26496172 |
| 54 | Abnormality of glycine metabolism (HP:0010895) | 3.14836041 |
| 55 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.14836041 |
| 56 | Abnormality of the pons (HP:0007361) | 3.14492886 |
| 57 | Flared iliac wings (HP:0002869) | 3.12301976 |
| 58 | Choanal stenosis (HP:0000452) | 3.08034041 |
| 59 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.05239553 |
| 60 | Hypomagnesemia (HP:0002917) | 3.04875588 |
| 61 | Tibial bowing (HP:0002982) | 3.03715746 |
| 62 | Carpal bone hypoplasia (HP:0001498) | 3.01220239 |
| 63 | Cortical dysplasia (HP:0002539) | 3.00779753 |
| 64 | Joint stiffness (HP:0001387) | 2.98475635 |
| 65 | Persistence of primary teeth (HP:0006335) | 2.90658882 |
| 66 | Abnormality of purine metabolism (HP:0004352) | 2.90473681 |
| 67 | Wormian bones (HP:0002645) | 2.90125777 |
| 68 | Proximal tubulopathy (HP:0000114) | 2.88620979 |
| 69 | Cranial hyperostosis (HP:0004437) | 2.86001365 |
| 70 | Femoral bowing (HP:0002980) | 2.80979473 |
| 71 | Abnormality of chloride homeostasis (HP:0011422) | 2.78481114 |
| 72 | Hypotension (HP:0002615) | 2.74598127 |
| 73 | Irregular vertebral endplates (HP:0003301) | 2.73311556 |
| 74 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.72499560 |
| 75 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.72499560 |
| 76 | Ankle contracture (HP:0006466) | 2.72127445 |
| 77 | Abnormal tarsal ossification (HP:0008369) | 2.71746126 |
| 78 | Tubulointerstitial abnormality (HP:0001969) | 2.69750759 |
| 79 | Metabolic alkalosis (HP:0200114) | 2.65238353 |
| 80 | Hypokalemic alkalosis (HP:0001949) | 2.65174839 |
| 81 | Vacuolated lymphocytes (HP:0001922) | 2.64948635 |
| 82 | Premature skin wrinkling (HP:0100678) | 2.62480948 |
| 83 | Wide anterior fontanel (HP:0000260) | 2.62363925 |
| 84 | Abnormality of magnesium homeostasis (HP:0004921) | 2.61155782 |
| 85 | Abnormality of the acetabulum (HP:0003170) | 2.57673341 |
| 86 | Enlarged epiphyses (HP:0010580) | 2.56046301 |
| 87 | Soft skin (HP:0000977) | 2.53630195 |
| 88 | Type 1 muscle fiber predominance (HP:0003803) | 2.53412609 |
| 89 | Spinal cord lesions (HP:0100561) | 2.50713828 |
| 90 | Syringomyelia (HP:0003396) | 2.50713828 |
| 91 | Follicular hyperkeratosis (HP:0007502) | 2.50442440 |
| 92 | Bladder diverticulum (HP:0000015) | 2.49234301 |
| 93 | Hyperextensible skin (HP:0000974) | 2.44045292 |
| 94 | Genu varum (HP:0002970) | 2.42422608 |
| 95 | Abnormality of the renal cortex (HP:0011035) | 2.40638218 |
| 96 | Congenital sensorineural hearing impairment (HP:0008527) | 2.38493068 |
| 97 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.37708792 |
| 98 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.35295686 |
| 99 | Coxa vara (HP:0002812) | 2.34647752 |
| 100 | Vascular calcification (HP:0004934) | 2.33274444 |
| 101 | Rickets (HP:0002748) | 2.31109567 |
| 102 | Osteomalacia (HP:0002749) | 2.30429625 |
| 103 | Neonatal short-limb short stature (HP:0008921) | 2.30235259 |
| 104 | Hypoplasia of the odontoid process (HP:0003311) | 2.29963284 |
| 105 | Methylmalonic aciduria (HP:0012120) | 2.29075054 |
| 106 | Barrel-shaped chest (HP:0001552) | 2.27497586 |
| 107 | Round ear (HP:0100830) | 2.25470099 |
| 108 | Dilatation of the ascending aorta (HP:0005111) | 2.21687066 |
| 109 | Optic nerve hypoplasia (HP:0000609) | 2.21241262 |
| 110 | Long foot (HP:0001833) | 2.20267527 |
| 111 | Increased circulating renin level (HP:0000848) | 2.19963019 |
| 112 | Late onset (HP:0003584) | 2.18873787 |
| 113 | Delayed cranial suture closure (HP:0000270) | 2.18512867 |
| 114 | Lymphangioma (HP:0100764) | 2.16377293 |
| 115 | Sudden death (HP:0001699) | 2.14863442 |
| 116 | Osteoarthritis (HP:0002758) | 2.13614482 |
| 117 | Mitral valve prolapse (HP:0001634) | 2.11648416 |
| 118 | Pectus carinatum (HP:0000768) | 2.10285855 |
| 119 | Hyperphosphatemia (HP:0002905) | 2.10032421 |
| 120 | Cardiovascular calcification (HP:0011915) | 2.09908305 |
| 121 | Absent eyebrow (HP:0002223) | 2.07014862 |
| 122 | Breast hypoplasia (HP:0003187) | 2.06559903 |
| 123 | Genu recurvatum (HP:0002816) | 2.05040803 |
| 124 | Dysostosis multiplex (HP:0000943) | 2.03398167 |
| 125 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.02860671 |
| 126 | Small epiphyses (HP:0010585) | 2.02469327 |
| 127 | Broad long bones (HP:0005622) | 2.02083849 |
| 128 | Enlarged penis (HP:0000040) | 1.99773210 |
| 129 | Abnormality of dentin (HP:0010299) | 1.99723626 |
| 130 | Abnormality of renin-angiotensin system (HP:0000847) | 1.99713836 |
| 131 | Increased corneal curvature (HP:0100692) | 1.99198172 |
| 132 | Keratoconus (HP:0000563) | 1.99198172 |
| 133 | Polyuria (HP:0000103) | 1.99042869 |
| 134 | Limited hip movement (HP:0008800) | 1.98828074 |
| 135 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.97374865 |
| 136 | Short middle phalanx of finger (HP:0005819) | 1.97031223 |
| 137 | Ventricular fibrillation (HP:0001663) | 1.96612131 |
| 138 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.95911365 |
| 139 | Vertebral compression fractures (HP:0002953) | 1.95612970 |
| 140 | Abnormality of Sharpey fibers (HP:0100685) | 1.95491385 |
| 141 | Acute encephalopathy (HP:0006846) | 1.95240146 |
| 142 | Glomerulosclerosis (HP:0000096) | 1.94064757 |
| 143 | Hyperaldosteronism (HP:0000859) | 1.93515473 |
| 144 | Broad phalanx (HP:0006009) | 1.93114837 |
| 145 | Dehydration (HP:0001944) | 1.92809558 |
| 146 | Aortic regurgitation (HP:0001659) | 1.92749778 |
| 147 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.92425775 |
| 148 | Abnormal protein glycosylation (HP:0012346) | 1.92425775 |
| 149 | Abnormal glycosylation (HP:0012345) | 1.92425775 |
| 150 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.92425775 |
| 151 | Metatarsus adductus (HP:0001840) | 1.92141697 |
| 152 | Generalized aminoaciduria (HP:0002909) | 1.91630987 |
| 153 | Prenatal maternal abnormality (HP:0002686) | 1.90706127 |
| 154 | Abnormal urine output (HP:0012590) | 1.90182763 |
| 155 | Tachypnea (HP:0002789) | 1.87742168 |
| 156 | Hypoventilation (HP:0002791) | 1.87562384 |
| 157 | Abnormality of the common coagulation pathway (HP:0010990) | 1.87004103 |
| 158 | Chronic hepatic failure (HP:0100626) | 1.86478613 |
| 159 | Abnormality of the odontoid process (HP:0003310) | 1.85463368 |
| 160 | Abnormality of the middle phalanges of the hand (HP:0009833) | 1.85224379 |
| 161 | Aplasia/Hypoplasia of the middle phalanges of the hand (HP:0009843) | 1.85219564 |
| 162 | Elbow flexion contracture (HP:0002987) | 1.85088746 |
| 163 | Bowel diverticulosis (HP:0005222) | 1.85017228 |
| 164 | Fatigue (HP:0012378) | 1.84875850 |
| 165 | Dicarboxylic aciduria (HP:0003215) | 1.84596754 |
| 166 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84596754 |
| 167 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.84556659 |
| 168 | Aortic valve stenosis (HP:0001650) | 1.83697972 |
| 169 | Narrow palate (HP:0000189) | 1.83671987 |
| 170 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.82453931 |
| 171 | Ovoid vertebral bodies (HP:0003300) | 1.82346528 |
| 172 | Aneurysm (HP:0002617) | 1.82004400 |
| 173 | Glycosuria (HP:0003076) | 1.81388741 |
| 174 | Abnormality of urine glucose concentration (HP:0011016) | 1.81388741 |
| 175 | Joint laxity (HP:0001388) | 1.81057214 |
| 176 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.79969127 |
| 177 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.79899241 |
| 178 | Abnormality of nucleobase metabolism (HP:0010932) | 1.79816910 |
| 179 | Abnormal cartilage morphology (HP:0002763) | 1.79546163 |
| 180 | Opisthotonus (HP:0002179) | 1.79191258 |
| 181 | Hyperammonemia (HP:0001987) | 1.77612631 |
| 182 | Absent frontal sinuses (HP:0002688) | 1.77119929 |
| 183 | Knee flexion contracture (HP:0006380) | 1.76453219 |
| 184 | Conjugated hyperbilirubinemia (HP:0002908) | 1.75415380 |
| 185 | Hypoplastic nipples (HP:0002557) | 1.75409284 |
| 186 | Abnormality of skull ossification (HP:0002703) | 1.75327071 |
| 187 | Hypoplasia of the uterus (HP:0000013) | 1.75192876 |
| 188 | Decreased skull ossification (HP:0004331) | 1.74945253 |
| 189 | Metabolic acidosis (HP:0001942) | 1.74308170 |
| 190 | Alkalosis (HP:0001948) | 1.73333162 |
| 191 | Mitral regurgitation (HP:0001653) | 1.72666940 |
| 192 | Termporal pattern (HP:0011008) | 1.72281130 |
| 193 | Insidious onset (HP:0003587) | 1.72281130 |
| 194 | Turricephaly (HP:0000262) | 1.71901815 |
| 195 | Osteolytic defects of the hand bones (HP:0009699) | 1.71742197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 9.22843835 |
| 2 | MAP2K2 | 4.33987307 |
| 3 | ERN1 | 4.13300927 |
| 4 | WNK4 | 3.84005427 |
| 5 | EIF2AK3 | 3.82429450 |
| 6 | PKN2 | 3.36354808 |
| 7 | TRIB3 | 3.23332586 |
| 8 | TLK1 | 2.89264576 |
| 9 | ZAK | 2.38239276 |
| 10 | FRK | 2.35094146 |
| 11 | STK39 | 2.19675828 |
| 12 | ZAP70 | 2.16378407 |
| 13 | MAP3K10 | 1.93078249 |
| 14 | LATS1 | 1.85857711 |
| 15 | INSRR | 1.80932522 |
| 16 | MAP2K1 | 1.79381477 |
| 17 | IRAK3 | 1.59871247 |
| 18 | AKT3 | 1.53737048 |
| 19 | MAPKAPK3 | 1.48780799 |
| 20 | ICK | 1.46377941 |
| 21 | MYLK | 1.40981441 |
| 22 | OXSR1 | 1.39753699 |
| 23 | MELK | 1.35174241 |
| 24 | PNCK | 1.33655989 |
| 25 | PAK2 | 1.32765392 |
| 26 | CDC7 | 1.28744428 |
| 27 | WNK3 | 1.28291667 |
| 28 | DAPK2 | 1.25664413 |
| 29 | CASK | 1.24718518 |
| 30 | ABL2 | 1.21164135 |
| 31 | MAPK7 | 1.20993485 |
| 32 | FGFR4 | 1.15344475 |
| 33 | PTK6 | 1.11592357 |
| 34 | NME1 | 1.10295503 |
| 35 | CAMK1G | 1.07871907 |
| 36 | CHUK | 1.07686806 |
| 37 | TAOK3 | 1.07250178 |
| 38 | PDGFRB | 1.05985505 |
| 39 | MAP3K2 | 1.03568170 |
| 40 | PRKCE | 1.03275879 |
| 41 | NLK | 1.02315971 |
| 42 | RPS6KB2 | 1.01477286 |
| 43 | NME2 | 1.00519640 |
| 44 | DYRK1A | 0.98922495 |
| 45 | LRRK2 | 0.98697156 |
| 46 | SIK1 | 0.96929946 |
| 47 | STK38L | 0.96628753 |
| 48 | STK3 | 0.95159626 |
| 49 | TGFBR2 | 0.95147349 |
| 50 | WNK1 | 0.92868456 |
| 51 | RET | 0.92242513 |
| 52 | KIT | 0.91808702 |
| 53 | TIE1 | 0.90721219 |
| 54 | MUSK | 0.89683752 |
| 55 | PDK2 | 0.85038353 |
| 56 | CDK12 | 0.83573850 |
| 57 | SIK3 | 0.81627074 |
| 58 | PIK3CG | 0.81325610 |
| 59 | EPHB2 | 0.80418508 |
| 60 | IRAK2 | 0.78477710 |
| 61 | ADRBK1 | 0.77761212 |
| 62 | PKN1 | 0.77040687 |
| 63 | EEF2K | 0.76962159 |
| 64 | CAMKK1 | 0.74870877 |
| 65 | MAPK15 | 0.73590941 |
| 66 | PINK1 | 0.72445690 |
| 67 | MAP2K6 | 0.72328458 |
| 68 | RIPK1 | 0.71425212 |
| 69 | CDK8 | 0.69767721 |
| 70 | SGK2 | 0.69753767 |
| 71 | RPS6KA5 | 0.69718819 |
| 72 | FLT3 | 0.67528408 |
| 73 | FER | 0.66404841 |
| 74 | VRK1 | 0.65913516 |
| 75 | PIK3CA | 0.64305625 |
| 76 | RPS6KA2 | 0.64210694 |
| 77 | TGFBR1 | 0.63252567 |
| 78 | BRD4 | 0.60772030 |
| 79 | BRSK2 | 0.59184838 |
| 80 | PRKCZ | 0.58450505 |
| 81 | PRKD2 | 0.56869985 |
| 82 | GRK7 | 0.55466794 |
| 83 | TSSK6 | 0.53941992 |
| 84 | CAMK2G | 0.53557008 |
| 85 | SGK223 | 0.53435041 |
| 86 | SGK494 | 0.53435041 |
| 87 | JAK1 | 0.53393025 |
| 88 | MST1R | 0.51543351 |
| 89 | SCYL2 | 0.51308978 |
| 90 | CDK4 | 0.50731582 |
| 91 | GRK1 | 0.49970487 |
| 92 | GRK5 | 0.49913947 |
| 93 | TESK1 | 0.49878744 |
| 94 | CHEK2 | 0.49387110 |
| 95 | CDK6 | 0.49189690 |
| 96 | PRKCI | 0.47339434 |
| 97 | CDC42BPA | 0.47003924 |
| 98 | ERBB4 | 0.46490254 |
| 99 | CDK3 | 0.46401730 |
| 100 | TRPM7 | 0.45961411 |
| 101 | IRAK1 | 0.45919929 |
| 102 | PRKCG | 0.45619285 |
| 103 | PTK2B | 0.45515528 |
| 104 | MTOR | 0.44432043 |
| 105 | MARK2 | 0.43935194 |
| 106 | PDPK1 | 0.42210241 |
| 107 | BMPR1B | 0.42172418 |
| 108 | DYRK3 | 0.41968258 |
| 109 | ROCK1 | 0.41137518 |
| 110 | DAPK3 | 0.39673415 |
| 111 | MAPK12 | 0.38469259 |
| 112 | PRKACB | 0.38260438 |
| 113 | KSR2 | 0.37758603 |
| 114 | IRAK4 | 0.36688369 |
| 115 | PRKCD | 0.36442451 |
| 116 | NTRK1 | 0.35467691 |
| 117 | PIM2 | 0.35280587 |
| 118 | EPHA3 | 0.34453198 |
| 119 | ADRBK2 | 0.34247732 |
| 120 | SGK3 | 0.33961721 |
| 121 | CDK7 | 0.33802790 |
| 122 | STK4 | 0.33187920 |
| 123 | RPS6KB1 | 0.31536772 |
| 124 | CAMK4 | 0.31304006 |
| 125 | MAPK3 | 0.29676694 |
| 126 | MAPKAPK5 | 0.29487840 |
| 127 | PTK2 | 0.29408866 |
| 128 | LATS2 | 0.28904024 |
| 129 | NEK6 | 0.28836729 |
| 130 | CAMK1D | 0.27827476 |
| 131 | STK38 | 0.27654322 |
| 132 | MAP3K7 | 0.27623055 |
| 133 | ILK | 0.26796178 |
| 134 | MAPK11 | 0.25831187 |
| 135 | HIPK2 | 0.25770912 |
| 136 | MAPK14 | 0.25753980 |
| 137 | PDK4 | 0.25492165 |
| 138 | PDK3 | 0.25492165 |
| 139 | AKT2 | 0.25337787 |
| 140 | NEK9 | 0.24995267 |
| 141 | PDK1 | 0.23276473 |
| 142 | PRKCH | 0.23075924 |
| 143 | MAP2K4 | 0.21628177 |
| 144 | EPHB1 | 0.21514581 |
| 145 | LMTK2 | 0.21205619 |
| 146 | DYRK1B | 0.21063631 |
| 147 | ABL1 | 0.20017987 |
| 148 | PAK4 | 0.19738414 |
| 149 | IGF1R | 0.19697788 |
| 150 | MATK | 0.18918183 |
| 151 | GSK3A | 0.18272340 |
| 152 | MET | 0.18192504 |
| 153 | DDR2 | 0.17912276 |
| 154 | RPS6KA1 | 0.16929087 |
| 155 | ERBB2 | 0.16547359 |
| 156 | PDGFRA | 0.16294613 |
| 157 | MAP3K1 | 0.15496045 |
| 158 | PRKACA | 0.15094629 |
| 159 | AKT1 | 0.14810993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Pancreatic secretion_Homo sapiens_hsa04972 | 7.59218705 |
| 2 | Protein digestion and absorption_Homo sapiens_hsa04974 | 5.74937896 |
| 3 | Fat digestion and absorption_Homo sapiens_hsa04975 | 5.54789763 |
| 4 | ECM-receptor interaction_Homo sapiens_hsa04512 | 4.96403744 |
| 5 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 3.09621779 |
| 6 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.07840895 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.07372507 |
| 8 | Focal adhesion_Homo sapiens_hsa04510 | 2.93556709 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.92667241 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.60909328 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.42682974 |
| 12 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 2.39152724 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.26093885 |
| 14 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.20050917 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.17381543 |
| 16 | Melanoma_Homo sapiens_hsa05218 | 1.99590710 |
| 17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.96991331 |
| 18 | Adherens junction_Homo sapiens_hsa04520 | 1.95559355 |
| 19 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.85975426 |
| 20 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.83485318 |
| 21 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.83418679 |
| 22 | Thyroid cancer_Homo sapiens_hsa05216 | 1.82188520 |
| 23 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.79219070 |
| 24 | Alcoholism_Homo sapiens_hsa05034 | 1.76130075 |
| 25 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.71040138 |
| 26 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.70285939 |
| 27 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.68512415 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.67307672 |
| 29 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.63758767 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.62199553 |
| 31 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.61720905 |
| 32 | Glioma_Homo sapiens_hsa05214 | 1.59305979 |
| 33 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.57736451 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.51366769 |
| 35 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.51220371 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.46806408 |
| 37 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.46671994 |
| 38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.37218210 |
| 39 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.36012519 |
| 40 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.33794430 |
| 41 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.31429456 |
| 42 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.30245108 |
| 43 | Colorectal cancer_Homo sapiens_hsa05210 | 1.29997125 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.23943196 |
| 45 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.19671079 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.17861366 |
| 47 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.17026996 |
| 48 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.13082309 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10403253 |
| 50 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.10380207 |
| 51 | Pathways in cancer_Homo sapiens_hsa05200 | 1.09464520 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.08796431 |
| 53 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.07935923 |
| 54 | Gap junction_Homo sapiens_hsa04540 | 1.05003557 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 1.03702636 |
| 56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.01222128 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97137458 |
| 58 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.96649314 |
| 59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.95925408 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94735045 |
| 61 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.93694927 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 0.93522922 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.92378162 |
| 64 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.91574539 |
| 65 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.89548127 |
| 66 | Axon guidance_Homo sapiens_hsa04360 | 0.86860142 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.84924249 |
| 68 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.84842172 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84617586 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.83337356 |
| 71 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.82728777 |
| 72 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82404062 |
| 73 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.81987369 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.81283091 |
| 75 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81178470 |
| 76 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.81124521 |
| 77 | Circadian rhythm_Homo sapiens_hsa04710 | 0.80566308 |
| 78 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.78926626 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78356337 |
| 80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.77528414 |
| 81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.75384175 |
| 82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.74816760 |
| 83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.71396058 |
| 84 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.70745325 |
| 85 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.69810013 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69296104 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.68068048 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.68015794 |
| 89 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.67505319 |
| 90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66486381 |
| 91 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.65622081 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62953117 |
| 93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60151569 |
| 94 | Influenza A_Homo sapiens_hsa05164 | 0.58381464 |
| 95 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.57420627 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56381494 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56350414 |
| 98 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56188085 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55897072 |
| 100 | * Insulin secretion_Homo sapiens_hsa04911 | 0.55476835 |
| 101 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55124461 |
| 102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54086356 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51925473 |
| 104 | Peroxisome_Homo sapiens_hsa04146 | 0.51668361 |
| 105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51426396 |
| 106 | Tight junction_Homo sapiens_hsa04530 | 0.50864644 |
| 107 | Cocaine addiction_Homo sapiens_hsa05030 | 0.50350793 |
| 108 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.49828646 |
| 109 | Cell cycle_Homo sapiens_hsa04110 | 0.49795776 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49294251 |
| 111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49120932 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48749653 |
| 113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.48473993 |
| 114 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 0.48187474 |
| 115 | Parkinsons disease_Homo sapiens_hsa05012 | 0.47925484 |
| 116 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.47201692 |
| 117 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46473051 |
| 118 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45987508 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45340282 |
| 120 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42725409 |
| 121 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.42495809 |
| 122 | Histidine metabolism_Homo sapiens_hsa00340 | 0.42301123 |
| 123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42161106 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.42146357 |
| 125 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.41927051 |
| 126 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41756157 |
| 127 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.41745987 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39689795 |
| 129 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.39488390 |
| 130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39229228 |
| 131 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39125231 |
| 132 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39120753 |
| 133 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37162627 |
| 134 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.37137764 |
| 135 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.36933261 |
| 136 | Carbon metabolism_Homo sapiens_hsa01200 | 0.36864915 |
| 137 | Hepatitis B_Homo sapiens_hsa05161 | 0.36731075 |
| 138 | Platelet activation_Homo sapiens_hsa04611 | 0.35174865 |
| 139 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34963670 |
| 140 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.34781159 |
| 141 | Alzheimers disease_Homo sapiens_hsa05010 | 0.34632080 |
| 142 | Lysosome_Homo sapiens_hsa04142 | 0.34445417 |
| 143 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32241020 |
| 144 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.32168561 |
| 145 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.31034345 |
| 146 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.30795104 |
| 147 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28737191 |
| 148 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.28414976 |
| 149 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.27659815 |
| 150 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26945614 |
| 151 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.26651210 |
| 152 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.25720069 |
| 153 | Bile secretion_Homo sapiens_hsa04976 | 0.25477983 |
| 154 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.23372200 |
| 155 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23013913 |
| 156 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.20948737 |
| 157 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.20157763 |
| 158 | Lysine degradation_Homo sapiens_hsa00310 | 0.18972922 |
| 159 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.18400989 |
| 160 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.17940984 |
| 161 | Legionellosis_Homo sapiens_hsa05134 | 0.17650050 |
| 162 | Sulfur relay system_Homo sapiens_hsa04122 | 0.17403846 |
| 163 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.14734077 |
| 164 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.10626517 |
| 165 | Taste transduction_Homo sapiens_hsa04742 | 0.06651317 |
| 166 | Prostate cancer_Homo sapiens_hsa05215 | 0.05209452 |
| 167 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.04911494 |
| 168 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.04106829 |
| 169 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.03314553 |
| 170 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.03125706 |
| 171 | Viral myocarditis_Homo sapiens_hsa05416 | 0.00340368 |
| 172 | Bladder cancer_Homo sapiens_hsa05219 | -0.0354995 |
| 173 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0206202 |
| 174 | Huntingtons disease_Homo sapiens_hsa05016 | -0.0193943 |
| 175 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | -0.0174567 |
| 176 | Hepatitis C_Homo sapiens_hsa05160 | -0.0135687 |

